naa a22 4500 510763901 CHVBK 20180411083149.0 cr unu---uuuuu 180411e20131001xx s 000 0 eng 10.1007/s12094-013-1011-7 doi (NATIONALLICENCE)springer-10.1007/s12094-013-1011-7 Study of survival in patients with malignant lung lesions treated with radiofrequency [Elektronische Daten] [J. Galbis Caravajal, J. Jornet Fayos, M. Cuenca Torres, E. Mollá Olmos, M. Estors Guerrero, F. Sánchez García, N. Martinez Hernandez, R. Esturi Navarro, A. Pastor del Campo, M. Vaño Molina] Objective: To report on the survival of a series of patients with primary and metastatic lung tumours treated with radiofrequency (RF). Four years ago we published our preliminary experience with the use of this technique. Materials and methods: For a period of 8years we have treated 59 patients (by means of a total of 70 procedures) with primary or metastatic pulmonary neoplastic lesions, which fulfilled inclusion criteria to perform the technique. They were in all cases non-surgical lesions that had been either previously treated or not. The technique was performed in the radiology suite, under conscious analgo-sedation. We treated primary pulmonary lesions, neoplastic recurrences, or metastases with curative or palliative intention (pain management). Results: Current global survival rate is 19 patients (32%) with a mean of 26.61±3.17months (range: 20.38±32.83) and a median of 16.00±3.57 (range: 8.99-23.00). If we establish the difference between primary and metastatic tumours, mean survival is 27.62±4.12months in primary tumours (median: 16.00) vs. 24.65±4.47months in metastatic tumours (median: 16.00). When we studied the survival in those cases with a curative intent, mean survival in primary tumours was 30.97±4.57months (median: 21.00) vs. 25.14±4.68 (median: 16.00) months in metastatic tumours. Conclusions: RF ablation of lung lesions is a minimally invasive procedure that is useful in primary tumours (especially in stage I) and metastatic ones. RF has proven its usefulness in the multidisciplinary treatment of this pathology due to the low incidence of serious complications and survival obtained, considering that patients are elderly with significant comorbidity. Federación de Sociedades Españolas de Oncología (FESEO), 2013 Radiofrequency ablation nationallicence Primary lung carcinoma nationallicence Lung metastases nationallicence Galbis Caravajal J. Department of Thoracic Surgery, La Ribera University Hospital, Alcira, Valencia, Spain aut Jornet Fayos J. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut Cuenca Torres M. Research and Educational Unit, La Ribera University Hospital, Alcira, Valencia, Spain aut Mollá Olmos E. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut Estors Guerrero M. Department of Thoracic Surgery, La Ribera University Hospital, Alcira, Valencia, Spain aut Sánchez García F. Department of Anaesthesia Intensive Care and Pain Management, La Ribera University Hospital, Alcira, Valencia, Spain aut Martinez Hernandez N. Department of Thoracic Surgery, La Ribera University Hospital, Alcira, Valencia, Spain aut Esturi Navarro R. Department of Anaesthesia Intensive Care and Pain Management, La Ribera University Hospital, Alcira, Valencia, Spain aut Pastor del Campo A. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut Vaño Molina M. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut Clinical and Translational Oncology Springer Milan 15/10(2013-10-01), 830-835 1699-048X 15:10<830 2013 15 12094 https://doi.org/10.1007/s12094-013-1011-7 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s12094-013-1011-7 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Galbis Caravajal J. Department of Thoracic Surgery, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Jornet Fayos J. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Cuenca Torres M. Research and Educational Unit, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Mollá Olmos E. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Estors Guerrero M. Department of Thoracic Surgery, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Sánchez García F. Department of Anaesthesia Intensive Care and Pain Management, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Martinez Hernandez N. Department of Thoracic Surgery, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Esturi Navarro R. Department of Anaesthesia Intensive Care and Pain Management, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Pastor del Campo A. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 700 1- Vaño Molina M. Department of Radiodiagnostics, La Ribera University Hospital, Alcira, Valencia, Spain aut NATIONALLICENCE 773 0- Clinical and Translational Oncology Springer Milan 15/10(2013-10-01), 830-835 1699-048X 15:10<830 2013 15 12094 Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer